Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study of Durvalumab, Tremelimumab, and Bevacizumab for Patients with Non-Resectable Liver Cancer

    Not recruiting

    1 1 1
    Germany Italy
  • Study on Adjustable Brodalumab Dosage for Patients with Moderate-to-Severe Plaque Psoriasis Weighing 120 kg or More

    Not recruiting

    1 1 1
    Investigated drugs:
    Belgium Czechia France Germany Greece Hungary +3
  • Study comparing stem cell transplantation versus alemtuzumab, cladribine or ocrelizumab in patients with aggressive relapsing-remitting multiple sclerosis

    Not recruiting

    1 1 1 1
    Denmark The Netherlands Norway Sweden
  • Study on the Safety and Effectiveness of Bezuclastinib for Patients with Advanced Systemic Mastocytosis

    Not recruiting

    1 1
    Austria Belgium France Germany Italy The Netherlands +3
  • Study of BAN2401 (lecanemab) in people with early stage Alzheimer’s disease to evaluate its effectiveness in preventing disease progression

    Not recruiting

    1 1 1 1
    Spain
  • Study Comparing Zanubrutinib with Bendamustine and Rituximab for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

    Not recruiting

    1 1 1 1
    Austria Belgium Czechia France Italy Poland +2
  • Study on Eye Health During Treatment with Mirvetuximab Soravtansine, Brimonidine Tartrate, and Prednisolone Acetate for Patients with Recurrent Ovarian Cancer

    Not recruiting

    1 1 1
    Investigated diseases:
    Belgium France Ireland Spain
  • Study on the Effectiveness and Safety of CHF 5993 Compared to CHF 1535 for Patients with Chronic Obstructive Pulmonary Disease (COPD)

    Not recruiting

    1 1
    Investigated diseases:
    Bulgaria Czechia Hungary Poland Romania
  • Study of Paclitaxel, Carboplatin, and Durvalumab with or without Oleclumab for Patients with Untreated Advanced Triple-Negative Breast Cancer

    Not recruiting

    1 1 1
    Belgium France
  • Study of Tamibarotene and Azacitidine Treatment in Newly Diagnosed Adults with RARA-positive Higher-risk Myelodysplastic Syndrome (MDS)

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium Czechia France Germany Hungary +3